LCPUFA Supplementation: A Multi-Modality Imaging Study
調査の概要
状態
条件
詳細な説明
LCPUFAs are essential fatty acids that are found in all cells of the body, particularly in the brain, retina and other nervous tissue. LCPUFAs are found naturally in seeds, nuts, fish and human breast milk. The body can also make LCPUFAs from shorter-chain fatty acid precursors.
The researchers in the study have previously found that LCPUFA supplementation during infancy has a beneficial effect on vision and development in the early years of life. However, researchers feel there is a growing need to better understand if there are structural and/or functional changes in the brain that explain these benefits. It is also important to understand if changes in development are still present later in childhood.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Kansas
-
Kansas City、Kansas、アメリカ、66160
- University of Kansas Medical Center
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Parents consent for children and children have the ability to assent
- Participation as an infant in the original study
Exclusion Criteria:
- Those with orthodontic braces or extensive dental work that would make them unable to have an MRI
研究計画
研究はどのように設計されていますか?
デザインの詳細
コホートと介入
グループ/コホート |
---|
Previous LCPUFA Supplementation
Children between the ages of 7 and 10 that were previously enrolled in a study of supplemented LCPUFA formula.
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Event-Related Field (ERF) Amplitude and Latency
時間枠:Within 1 year post enrollment
|
We will use an MEG Event-Related Field (ERF) to study the development of children's cognitive capabilities.
The waveform components associated with information processing and response inhibition will be measured in order to assess the developmental progress of LCPUFA effects with increasing age.
|
Within 1 year post enrollment
|
Regional gray and white matter brain volume
時間枠:Within 1 year post enrollment
|
Structural brain imaging is widely used to measure gray and white matter maturation patterns in young children.
We will use automated, sensitive, and validated methods to test whether LCPUFA supplementation positively impacts changes in the brain associated with higher functioning and intelligence.
|
Within 1 year post enrollment
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
---|---|---|
Identify structural and metabolic mediators
時間枠:Within 1 year post enrollment
|
In a single imaging session, we will measure metabolic biomarkers associated with cellular mechanisms such as bioenergetics, membrane status, and oxidative state, each of which have been implicated as associated with LCPUFA supplementation.
|
Within 1 year post enrollment
|
協力者と研究者
捜査官
- 主任研究者:Kathleen M Gustafson, PhD、University of Kansas Medical Center
出版物と役立つリンク
研究記録日
主要日程の研究
研究開始
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (見積もり)
学習記録の更新
投稿された最後の更新 (見積もり)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
キーワード
その他の研究ID番号
- LCPUFA Supplementation
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。
小児発達の臨床試験
-
Boehringer Ingelheim利用できない肺疾患、間質性(小児集団) | 小児間質性肺疾患 (chILD)
-
AstraZeneca終了しました胃癌 | 進行性固形悪性腫瘍 | 固形腫瘍 | Child-Pugh A ~ B7 進行肝細胞がん | EGFRおよび/またはROS変異NSCLC | 肺転移がん大韓民国